Correlation Between M Yochananof and Clal Biotechnology

Can any of the company-specific risk be diversified away by investing in both M Yochananof and Clal Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining M Yochananof and Clal Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between M Yochananof and and Clal Biotechnology Industries, you can compare the effects of market volatilities on M Yochananof and Clal Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in M Yochananof with a short position of Clal Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of M Yochananof and Clal Biotechnology.

Diversification Opportunities for M Yochananof and Clal Biotechnology

-0.64

Correlation Coefficient

M Yochananof  Clal Biotechnology

Excellent diversification

The 3 months correlation between YHNF and Clal is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding M Yochananof and and Clal Biotechnology Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clal Biotechnology and M Yochananof is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on M Yochananof and are associated (or correlated) with Clal Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clal Biotechnology has no effect on the direction of M Yochananof i.e., M Yochananof and Clal Biotechnology go up and down completely randomly.

Pair Corralation between M Yochananof and Clal Biotechnology

Assuming the 90 days trading horizon M Yochananof and is expected to under-perform the Clal Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, M Yochananof and is 1.92 times less risky than Clal Biotechnology. The stock trades about -0.33 of its potential returns per unit of risk. The Clal Biotechnology Industries is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest  3,650  in Clal Biotechnology Industries on September 13, 2024 and sell it today you would lose (150.00) from holding Clal Biotechnology Industries or give up 4.11% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

M Yochananof and  vs.  Clal Biotechnology Industries

M Yochananof

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in M Yochananof and are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, M Yochananof is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Clal Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with M Yochananof and Clal Biotechnology

The main advantage of trading using opposite M Yochananof and Clal Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if M Yochananof position performs unexpectedly, Clal Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Biotechnology will offset losses from the drop in Clal Biotechnology's long position.

The idea behind M Yochananof and and Clal Biotechnology Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.